Skip to main content

Table 3 Calculated daily nutrient intake at baseline and after four weeks of supplementation 1

From: Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study

Nutrient   Baseline (week 0) Supplementation (week 4)
   Placebo Low-ARA High-ARA Placebo Low-ARA High-ARA
Energy kcal/d 1871 ± 483 1779 ± 439 2017 ± 636 1973 ± 550 1748 ± 410 1945 ± 497
Protein g/d 73.4 ± 21.6 67.1 ± 17.2 78.0 ± 22.2 74.6 ± 21.4 68.9 ± 17.8 77.0 ± 21.4
Carbohydrate g/d 256 ± 68 234 ± 82 260 ± 91 278 ± 76 227 ± 63 259 ± 74
Total fat g/d 56.0 ± 19.1 52.8 ± 16.6 61.0 ± 21.9 56.5 ± 22.3 52.4 ± 14.8 57.5 ± 16.8
SFA g/d 16.2 ± 6.3 14.7 ± 5.0 16.3 ± 6.7 15.5 ± 8.1 14.1 ± 4.4 15.2 ± 5.2
MUFA g/d 19.3 ± 7.0 18.4 ± 6.4 21.8 ± 8.2 19.6 ± 7.6 18.4 ± 5.7 20.4 ± 6.1
PUFA g/d 13.1 ± 4.6 12.7 ± 3.6 14.8 ± 4.7 13.8 ± 4.3 12.8 ± 3.4 14.1 ± 4.0
18:2n-6 g/d 9.96 ± 3.52 9.76 ± 2.85 11.12 ± 3.60 10.59 ± 3.34 9.71 ± 2.56 10.74 ± 3.05
20:4n-6 mg/d 174 ± 56 170 ± 71 199 ± 74 172 ± 67 174 ± 73 189 ± 66
18:3n-3 g/d 1.61 ± 0.61 1.52 ± 0.48 1.79 ± 0.62 1.67 ± 0.57 1.51 ± 0.41 1.71 ± 0.51
20:5n-3 mg/d 377 ± 215 315 ± 172 447 ± 163 366 ± 197 367 ± 190 399 ± 202
22:6n-3 mg/d 616 ± 323 538 ± 267 729 ± 261 600 ± 289 611 ± 301 658 ± 306
  1. 1Values are means ± SD (n = 20, placebo group; n = 22, low-ARA; n = 22, high-ARA). No significant differences between time points (Student's t-test) or groups (ANOVA and Tukey-Kramer test).
  2. 2SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; 18:2n-6, linoleic acid; 20:4n-6, arachidonic acid; 18:3n-3, α-linolenic acid; 20:5n-3, eicosapentaenoic acid; and 22:6n-3, docosahexaenoic acid.